USFDA approves Alembic Pharma's generic heart failure tablets
The approved medication is Sacubitril and Valsartan Tablets, available in strengths of 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg.
Stay updated with breaking news from Alembic Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The approved medication is Sacubitril and Valsartan Tablets, available in strengths of 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg.
Young graduates from GSFC University in Gujarat, with a degree in BTech in Fire & EHS, are achieving record placements, surpassing CSE graduates in sa
Sudeep Shah of SBI Securities analyzes Alembic Pharma and Coal India breakouts, India VIX rise, and Bank Nifty performance. He suggests trading strategies amidst market uncertainties and stock-specific trends.
After consistent double-digit growth in the branded formulations business in recent years, growth in the domestic formulation segment has moderated to high single digits.
Leading therapies like cardiac, anti-infectives, and gastro-intestinal recorded robust volume growth in MAT figures, constituting 37.5% of IPM.